Michael Cima

Michael J. Cima, Ph.D., is a co-founder and consultant to the TARIS Biomedical management team. Michael Cima is also a Professor of Materials Science and Engineering at the Massachusetts Institute of Technology (MIT) and an investigator at the Koch Institute for Integrative Cancer Research at MIT.

Professor Cima is author or co-author of over 190 peer reviewed scientific publications, 45 patents, and is a recognized expert in the field of materials processing. He is actively involved in materials and engineered systems aimed at improving human health; such as treatments for cancer, metabolic diseases, trauma, and urological disorders. Professor Cima and collaborators are developing implantable devices for unprecedented control in the delivery of pharmaceuticals.

Professor Cima is co-founder and a director of MicroChips Inc. and T2 Biosystems. Most recently, Professor Cima co-founded Entra Pharmaceuticals and TARIS Biomedical.

Professor Cima earned a B.S. in chemistry (Phi Beta Kappa) and a Ph.D. in chemical engineering, both from the University of California at Berkeley. Professor joined the MIT faculty in 1986 and was promoted to full Professor in 1995.

Michael Cima is the Director at TARIS Biomedical, based in United States, North America. With a background in Biotechnology, Michael Cima has a rich history of leadership and innovation.Michael Cima studied Ph.D Chemical Engineering at University of California Berkeley. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.